I 
119TH CONGRESS 
1ST SESSION H. R. 3873 
To increase funding for cancer research by the National Cancer Institute 
to be more in proportion to the mortality rates of cancer. 
IN THE HOUSE OF REPRESENTATIVES 
JUNE 10, 2025 
Mr. FITZPATRICK (for himself and Mrs. DINGELL) introduced the following 
bill; which was referred to the Committee on Appropriations, and in addi-
tion to the Committee on Energy and Commerce, for a period to be sub-
sequently determined by the Speaker, in each case for consideration of 
such provisions as fall within the jurisdiction of the committee concerned 
A BILL 
To increase funding for cancer research by the National 
Cancer Institute to be more in proportion to the mor-
tality rates of cancer. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Knock Out Cancer 
Act’’ or the ‘‘KO Cancer Act’’. 
SEC. 2. FINDINGS. 
Congress finds the following: 
VerDate Sep 11 2014 
03:20 Jun 12, 2025
Jkt 059200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H3873.IH
H3873
kjohnson on DSK7ZCZBW3PROD with $$_JOB
(1) Cancer is one of the leading causes of death 
in the world and has touched nearly every life, either 
directly or indirectly. 
(2) Cancer is the cause of nearly 1 out of every 
4 deaths in the United States, since 2000 totaling 
over 15 million American lives. 
(3) Efforts to increase awareness of cancer 
symptoms among patients and clinicians would lead 
to earlier detection and improvements in survival 
rates. 
(4) Scientific understanding and research lead 
to innovations in effective treatments, controls, and 
cures for cancer. 
(5) The National Cancer Institute has been a 
leader in finding medical breakthroughs for treat-
ment and therapies for cancer patients. 
(6) Through substantial investment in cancer 
research, potentially even the tripling of necessary 
funding, the United States will be best able to ad-
dress the mortality rates of cancer and the impacts 
on the patient population. 
SEC. 3. INCREASING NCI BUDGET FOR CANCER RESEARCH. 
To conduct or support cancer research, there is here-
by appropriated, for each of fiscal years 2026 through 
2030, to the National Cancer Institute, out of amounts 
VerDate Sep 11 2014 
03:20 Jun 12, 2025
Jkt 059200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H3873.IH
H3873
kjohnson on DSK7ZCZBW3PROD with $$_JOB
in the Treasury not otherwise appropriated, an amount 
that is equal to 25 percent of the total amount appro-
priated to the National Cancer Institute for fiscal year 
2022, to remain available until expended. Amounts appro-
priated pursuant to the preceding sentence shall be in ad-
dition to amounts otherwise made available to the Na-
tional Cancer Institute. 
SEC. 4. REPORT TO CONGRESS ON CANCER DRUG SHORT-
AGES. 
(a) STUDY.—The Secretary of Health and Human 
Services, acting through the Commissioner of Food and 
Drugs, in collaboration with such other agencies as the 
Secretary deems necessary, shall study the reasons for 
cancer drug shortages, including— 
(1) economic reasons; 
(2) supply chain failures; 
(3) delays and other complications relating to— 
(A) the development of cancer drugs; and 
(B) the approval of such drugs by the 
Food and Drug Administration; and 
(4) insufficient generic drugs and biosimilar bi-
ological products. 
(b) REPORT.— 
(1) IN GENERAL.—Not later than 1 year after 
the date of enactment of this Act, the Secretary of 
VerDate Sep 11 2014 
03:20 Jun 12, 2025
Jkt 059200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H3873.IH
H3873
kjohnson on DSK7ZCZBW3PROD with $$_JOB
Health and Human Services, acting through the 
Commissioner of Food and Drugs, shall complete 
the study under subsection (a) and submit a report 
to the appropriate committees of the Congress on 
the results of such study. 
(2) RECOMMENDATIONS.—The report under 
paragraph (1) shall include recommendations for ad-
dressing the reasons for cancer drug shortages. 
Æ 
VerDate Sep 11 2014 
03:20 Jun 12, 2025
Jkt 059200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6301
E:\BILLS\H3873.IH
H3873
kjohnson on DSK7ZCZBW3PROD with $$_JOB